NCT06100770 - Aveir AR Coverage With Evidence Development (CED) Study | Biotech Hunter

Enrollment

586

Participants

Timeline

Start Date

January 18, 2024

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2031

Conditions

Cardiac PacemakerArrhythmiaBradycardia

Interventions

DEVICE

Aveir AR Leadless Pacemaker

This study will utilize real-world data from patients implanted with the Aveir AR Leadless Pacemaker. No device intervention is required in this study.

DEVICE

Single-chamber atrial transvenous pacemaker

This study will utilize real-world data from patients implanted with a single-chamber atrial transvenous pacemaker as a comparator to the Aveir AR LP study arm. No device intervention is required in this study

Trial Locations (1)

91342

RECRUITING

Abbott, Sylmar